Dr. Clay Quint, MD PhD
Claim this profileMore about Clay Quint, MD PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Clay Quint, MD PhD has experience with
- Coronary Computed Topography (CT) Angiography With FFR-CT
Breakdown of trials Clay Quint, MD PhD has run
Coronary Artery Disease
Peripheral Artery Disease
Peripheral Arterial Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Clay Quint, MD PhD specialize in?
Clay Quint, MD PhD focuses on Coronary Artery Disease and Peripheral Artery Disease. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Clay Quint, MD PhD currently recruiting for clinical trials?
No, Clay Quint, MD PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Clay Quint, MD PhD has studied deeply?
Yes, Clay Quint, MD PhD has studied treatments such as Coronary computed topography (CT) angiography with FFR-CT.
What is the best way to schedule an appointment with Clay Quint, MD PhD?
Apply for one of the trials that Clay Quint, MD PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.